The present and future role of photodynamic therapy in cancer treatment

Lancet Oncology

Volumn 5, Issue 8, 2004, Pages 497-508

  Brown, Stanley B ^a   Brown, Elizabeth A ^a   Walker, Ian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; BACTERIOCHLORIN; BENZOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN DERIVATIVE; OMEPRAZOLE; PHENOTHIAZINE DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; PROTOPORPHYRIN; TEMOPORFIN; TEXAFRIN DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ACTINIC KERATOSIS; ADVANCED CANCER; BARRETT ESOPHAGUS; BASAL CELL CARCINOMA; BLADDER CANCER; BOWEN DISEASE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CLINICAL TRIAL; DAY CARE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BRAIN LEVEL; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; EPITHELIUM TUMOR; ESOPHAGUS CARCINOMA; GLIOBLASTOMA; HEAD AND NECK CANCER; HEALING; HEALTH CARE COST; HUMAN; HYPOPHYSIS TUMOR; LUNG NON SMALL CELL CANCER; OUTPATIENT CARE; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SKIN CANCER; TREATMENT OUTCOME; CONTROLLED CLINICAL TRIAL; NEOPLASM; OUTPATIENT; PHASE 3 CLINICAL TRIAL; PHOTOCHEMOTHERAPY; PRECANCER; RANDOMIZED CONTROLLED TRIAL; SKIN TUMOR;

CLINICAL TRIALS, PHASE III; HUMANS; NEOPLASMS; OUTPATIENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRECANCEROUS CONDITIONS; RANDOMIZED CONTROLLED TRIALS; SKIN NEOPLASMS;

EID: 4043107044     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(04)01529-3     Document Type: Review

References (87)

1. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer Lancet Oncol 1 2000 212-219
2. Gomer C J Ferrario A Fisher AMR et al. Photodynamic therapy: basic mechanisms and molecular applications In: Coohill TP Valenzeno DP eds. Photobiology for the 21st century 2001 143-147 Valdenmar Publishing Company Overland Park Kansas
3. Oleinick NL Morris RL Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how Photochem Photobiol Sci 1 2002 1-21
4. Henderson BW Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 55 1992 145-157
5. Barrett AJ Kennedy JC Jones RA et al. The effect of tissue and cellular pH on the selective biodistribution of porphyrin-type photochemotherapeutic agents: a volumetric titration study J Photochem Photobiol B 6 1990 309-323
6. Dougherty TJ Gomer CJ Henderson BW et al. Photodynamic therapy J Natl Cancer Inst 90 1998 889-905
7. Ochsner M. Light scattering of human skin: a comparison between zinc (II)- phthalocyanine and photofrin II J Photochem Photobiol B 32 1996 3-9
8. Star WM. Light dosimetry in vivo Phys Med Biol 42 1997 763-787
9. Brancaleon L Moseley H. Laser and non-laser light sources for photodynamic therapy Lasers Med Sci 17 2002 173-186
10. Sharman WM Allen CM van Lier JE. Photodynamic therapeutics: basic principles and clinical applications Drug Discov Today 4 1999 507-517
11. Ackroyd R Kelty C Brown N Reed M. The history of photodetection and photodynamic therapy Photochem Photobiol 74 2001 656-669
12. Moriwaki SI Misawa J Yoshinari Y et al. Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin) Photodermatol Photoimmunol Photomed 17 2001 241-243
13. Gilson D Ash D Driver I et al. Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man Br J Cancer 58 1988 665-667
14. Brown SB Mellish KJ. Verteporfin: a milestone in opthalmology and photodynamic therapy Expert Opin Pharmacother 2 2001 351-361
15. Messmer KJ Abel SR. Verteporfin for age-related macular degeneration Ann Pharmacother 35 2001 1593-1598
16. Polo L Valduga G Jori G Reddi E. Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts Int J Biochem Cell Biol 34 2002 10-23
17. Preston DS Stern RS. Nonmelanoma cancers of the skin N Engl J Med 327 1992 1649-1662
18. Morton CA Brown SB Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group Br J Dermatol 146 2002 552-567
19. Chang SC Bown SG. Photodynamic therapy: applications in bladder cancer and other malignancies J Formos Med Assoc 96 1997 853-863
20. Kubler AC de Carpentier J Hopper C et al. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy Int J Oral Maxillofac Surg 30 2001 504-509
21. Kubler AC Haase T Staff C et al. Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck Lasers Surg Med 25 1999 60-68
22. Ormrod D Jarvis B. Topical aminolevulinic acid HCl photodynamic therapy Am J Clin Dermatol 1 2000 133-139
23. Piacquadio DJ Chen DM Farber HF et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials Arch Dermatol 140 2004 41-46
24. Szeimies RM Karrer S Radakovic-Fijan S et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study J Am Acad Dermatol 47 2002 258-262
25. Freeman M Vinciullo C Francis DA. et al. comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study J Dermatol Treat 14 2003 99-106
26. Smith S Piacquadio D Morhenn V et al. Short incubation PDT versus 5-FU in treating actinic keratoses J Drugs Dermatol 2 2003 629-635
27. Pariser DM Lowe NJ Stewart D M et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial J Am Acad Dermatol 48 2003 227-232
28. Jeffes EW McCullough JL Weinstein GD et al. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light J Am Acad Dermatol 45 2001 96-104
29. Varma S Wilson H Kurwa HA et al. Bowen's disease, solar keratoses, and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source Br J Dermatol 144 2001 567-574
30. Wang I Bendsoe N Klinteberg CA et al. Photodynamic therapy vs cryosurgery of basal cell carcinomas: results of a phase III clinical trial Br J Dermatol 144 2001 832-840
31. Horn M Wolf P Wulf HC et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment Br J Dermatol 149 2003 1242-1249
32. Dijkstra AT Majoie IM van Dongen JW et al. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma J Eur Acad Dermatol Venereol 15 2001 550-554
33. Salim A Leman JA McColl JH et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease Br J Dermatol 148 2003 539-543
34. Morton CA Whitehurst C Moore JV MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy Br J Dermatol 143 2000 767-772
35. Rhodes LE De Rie M Enstrom Y et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial Arch Dermatol 140 2004 17-23
36. Soler AM Warloe T Berner A Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage Br J Dermatol 145 2001 467-471
37. Basset-Seguin N Ibbotson S Emtestam Lea. Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results J Eur Acad Dermatol Venereol 15 2001 226
38. Allison RR Mang TS Wilson BD. Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies Semin Cutan Med Surg 17 1998 153-163
39. Ackroyd R Brown NJ Davis MF. et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial Gut 47 2000 612-617
40. Overholt BF Lightdale CJ Wang K et al. International multicenter partially blinded randomised study of the efficacy of photodynamic therapy using porfimer sodium for the ablation of high-grade dysplasia in Barrett's esophagus: results of 24 month follow-up Gastroenterology 124 suppl 2003 151
41. Barnett AA Haller JC Cairnduff F et al. A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia Int J Cancer 103 2003 829-832
42. Keefe KA Tadir Y Tromberg B et al. Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid Lasers Surg Med 31 2002 289-293
43. Panjehpour M Overholt BF Haydek JM Lee SG. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation Am J Gastroenterol 95 2000 2177-2184
44. Ackroyd R Brown NJ Davis MF et al. Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus Dis Esophagus 13 2000 18-22
45. Fehr MK Hornung R Schwarz VA et al. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid Gynecol Oncol 80 2001 62-66
46. Hillemanns P Untch M Dannecker C et al. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid Int J Cancer 85 2000 649-653
47. Regula J Macrobert AJ Gorchein A et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX:a pilot study Gut 36 1995 67-75
48. Barr H Shepherd NA Dix A et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX Lancet 348 1996 584-585
49. Gossner L Stolte M Sroka R et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid Gastroenterology 114 1998 448-455
50. Ackroyd R Brown NJ Vernon D et al. Photodynamic therapy (PDT) for Barrett's oesophagus: a dosimetric pilot study Br J Surg 83 1996 1637
51. Ackroyd R Brown NJ Reed M. Photodynamic therapy (PDT) for Barrett's oesophagus: establishing optimal treatment parameters Eur J Surg Oncol 22 1996 551
52. Kelty CJ Marcus SL Ackroyd R. Photodynamic therapy for Barrett's esophagus: a review Dis Esophagus 15 2002 137-144
53. Nseyo UO Shumaker B Klein EA Sutherland K. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder J Urol 160 1998 39-44
54. D'Hallewin MA Baert L. Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder Urology 45 1995 763-767
55. Waidelich R Beyer W Knuchel R et al. Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source Urology 61 2003 332-337
56. Mathur PN Edell E Sutedja T Vergnon JM. Treatment of early stage non-small cell lung cancer Chest 123 suppl 2003 S176-S180
57. Marks PV Belchetz PE Saxena A et al. Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial-an early report Br J Neurosurg 14 2000 317-325
58. Muller PJ Wilson BC. Photodynamic therapy for malignant newly diagnosed supratentorial gliomas J Clin Laser Med Surg 14 1996 263-270
59. Popovic E.A Kaye AH Hill JS. Photodynamic therapy of brain tumors J Clin Laser Med Surg 14 1996 251-261
60. Zimmermann A Ritsch-Marte M Kostron H. mTHPC-mediated photodynamic diagnosis of malignant brain tumors Photochem Photobiol 74 2001 611-616
61. Lou PJ Jones L Hopper C. Clinical outcomes of photodynamic therapy for head-and-neck cancer Technol Cancer Res Treat 2 2003 311-317
62. Ortner ME Caca K Berr F et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study Gastroenterology 125 2003 1355-1363
63. Friedberg JS Mick R Stevenson J et al. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma Ann Thorac Surg 75 2003 952-959
64. Maier A Tomaselli F Matzi V et al. Comparison of 5-aminolaevulinic acid and porphyrin photosensitization for photodynamic therapy of malignant bronchial stenosis: a clinical pilot study Lasers Surg Med 30 2002 12-17
65. Tomaselli F Maier A Sankin O et al. Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer - a clinical pilot study Lasers Surg Med 28 2001 399-403
66. Tomaselli F Maier A Pinter H et al. Photodynamic therapy enhanced by hyperbaric oxygen in acute endoluminal palliation of malignant bronchial stenosis (clinical pilot study in 40 patients) Eur J Cardiothorac Surg 19 2001 549-554
67. Dilkes MG Benjamin E Ovaisi S Banerjee AS. Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases J Laryngol Otol 117 2003 713-717
68. Copper MP Tan IB Oppelaar H et al. Meta-tetra(hydroxyphenyl) chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck Arch Otolaryngol Head Neck Surg 129 2003 709-711
69. Menon C Kutney SN Lehr SC et al. Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy Clin Cancer Res 7 2001 3904-3911
70. Hendren SK Hahn SM Spitz FR et al. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors Ann Surg Oncol 8 2001 65-71
71. Bauer TW Hahn SM Spitz FR et al. Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis Ann Surg Oncol 8 2001 254-259
72. Canter RJ Mick R Kesmodel SB et al. Intraperitoneal photodynamic therapy causes a capillary-leak syndrome Ann Surg Oncol 10 2003 514-524
73. Nathan TR Whitelaw DE Chang SC et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study J Urol 168 2002 1427-1432
74. Maier A Tomaselli F Matzi V et al. Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma? Lasers Surg Med 29 2001 323-327
75. Luketich JD Christie NA Buenaventura PO et al. Endoscopic photodynamic therapy for obstructing esophageal cancer: 77 cases over a 2-year period Surg Endosc 14 2000 653-657
76. Berr F Wiedmann M Tannapfel A et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival Hepatology 31 2000 291-298
77. Barber P Barr H George J et al. Photodynamic therapy in the treatment of lung and oesophageal cancers Clin Oncol (R Coll Radiol) 14 2002 110-116
78. Moghissi K Dixon K Stringer M et al. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases Eur J Cardiothorac Surg 15 1999 1-6
79. Ost D. Photodynamic therapy in lung cancer: a review Methods Mol Med 75 2003 507-526
80. Moghissi K Dixon K. Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer? Eur Respir J 22 2003 535-541
81. Bown SG Rogowska AZ Whitelaw DE et al. Photodynamic therapy for cancer of the pancreas Gut 50 2002 549-557
82. Hahn SM Smith RP Friedberg J. Photodynamic therapy for mesothelioma Curr Treat Options Oncol 2 2001 375-383
83. Dougherty TJ. An update on photodynamic therapy applications J Clin Laser Med Surg 20 2002 3-7
84. Pass HI DeLaney TF Tochner Z et al. Intrapleural photodynamic therapy: results of a phase I trial Ann Surg Oncol 1 1994 28-37
85. Brokx RD Bisland SK Gariepy J. Designing peptide-based scaffolds as drug delivery vehicles J Control Release 78 2002 115-123
86. Konan YN Gurny R Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy J Photochem Photobiol B 66 2002 89-106
87. Allen CM Sharman WM van Lier JE. Photodynamic therapy: targeting cancer cells with photosensitiser-bioconjugates in: Page M ed. Tumour targeting in cancer therapy 2002 329-361 Humana Press Totowa, NJ